3682 Outcomes of deprescribing for older people with life-limiting conditions: a systematic review
Outcomes des Deprescribing bei älteren Menschen mit lebensbegrenzenden Erkrankungen: systematische Übersichtsarbeit
Age and Ageing · 05.02.2026 · 55 (Supplement_1)
DOI: 10.1093/ageing/afaf368.164 ↗Auf einen Blick
Die Übersichtsarbeit zeigt: Deprescribing war häufig mit einer geringeren Medikamentenlast verbunden. In den meisten Studien verschlechterten sich die untersuchten Outcomes nicht.
Fragestellung
Welche Outcomes hat Deprescribing von Medikamenten bei älteren Menschen mit lebensbegrenzenden Erkrankungen?
Methode
Systematische Übersichtsarbeit; Suche in MEDLINE, Embase, Scopus, PsycINFO und CINAHL; eingeschlossen wurden englischsprachige Originalstudien von Januar 2000 bis Dezember 2024.
Ergebnisse
46 Studien nach Screening von 17.457 Treffern. Meist pre-post-interventionelle Studien (n = 14) und Kohortenstudien (n = 14). Medikamentenzahl: in 15 Studien Reduktion, in 3 kein signifikanter Unterschied. Mortalität/Überleben: 16 Studien, davon 4 mit verbessertem und 4 mit vermindertem Überleben.
Schlussfolgerung der Autor:innen
Die Autor:innen schlussfolgern, dass Deprescribing mehrere günstige Outcomes haben kann, darunter weniger Medikamentenlast und geringere Gesundheitskosten. Es gibt keine starke Evidenz für Schaden, aber ein kleiner Teil der Patient:innen kann Risiken haben.
Kernaussagen
- 46 Studien wurden eingeschlossen
- Weniger Medikamente oder unveränderte Medikation in den meisten Studien
- Mortalität und Überleben zeigten gemischte Ergebnisse
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Systematische Übersicht in der Zeitschrift Age and Ageing, online erschienen am 05.02.2026. Verfasst von R Shrestha und 5 weiteren Autor:innen.
Themen: Gerontologische Pflege
Abstract (Originalsprache)
Introduction
Polypharmacy and potentially inappropriate prescribing are common in older people with life-limiting conditions. While deprescribing—a structured approach to reducing or discontinuing medications—is one approach to address this, its impact in this population is not well understood. Therefore, this systematic review aimed to synthesise evidence on outcomes of deprescribing medication in this population.
Method
A systematic search of MEDLINE, Embase, Scopus, PyscINFO and CINAHL was conducted to identify original studies reporting clinical-, medication-, and system-related outcomes of deprescribing. Studies published in English between January 2000 and December 2024 were included and analysed.
Results
A total of 17,457 studies were screened, of which 46 met the eligibility criteria. Most of them were pre-post interventional (n = 14) and cohort studies (n = 14), conducted in nursing homes/long-term care facilities (n = 19) and hospitals (n = 14). Studies were mostly conducted in the North America (n = 20) and Europe (n = 14).
Results
A broad range of outcomes were reported in the literature, predominantly on clinical-related outcomes. Particularly, medication reduction, and mortality and survival outcomes were the most common. All studies assessing the impact on the number of medications used reported either a reduction in overall medication burden or inappropriate medications (n = 15), or no significant change (n = 3). Mortality and survival outcomes were reported in 16 studies: 4 each showed improved survival and reduced survival, and the remainder found no significant change. For other outcomes, the studies showed that deprescribing did not generally worsen the outcomes in the majority cases.
Conclusion
This systematic review suggests that deprescribing has several beneficial outcomes, including reducing medication burden and healthcare cost. While there is no strong evidence for harm, a small proportion of patients may face risks, so a careful monitoring is essential. Further studies should explore how outcome vary by disease conditions and medication types.
Zitieren
APA
Shrestha, R., Shaw, E., Mullen, L., Sinclair, D., Dewhurst, F., & Todd, A. (2026). 3682 Outcomes of deprescribing for older people with life-limiting conditions: a systematic review. Age and Ageing, 55(Supplement_1). https://doi.org/10.1093/ageing/afaf368.164
Vancouver
Shrestha R, Shaw E, Mullen L, Sinclair D, Dewhurst F, Todd A. 3682 Outcomes of deprescribing for older people with life-limiting conditions: a systematic review. Age and Ageing. 2026;55(Supplement_1). doi:10.1093/ageing/afaf368.164
BibTeX
@article{Shrestha2026,
author = {Shrestha, R and Shaw, E and Mullen, L and Sinclair, D and Dewhurst, F and Todd, A},
title = {3682 Outcomes of deprescribing for older people with life-limiting conditions: a systematic review},
journal = {Age and Ageing},
year = {2026},
volume = {55},
number = {Supplement_1},
doi = {10.1093/ageing/afaf368.164}
}
EUVIMED